RxDoctor Payments DataLook up a doctor →

Loren Cragle, PA

Physician Assistant · Greer, SCNPI 1538406491

Payments from drug & device makers

$32,623in general payments, 2019–2025

Across 472 payments — averaging $69.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • EMD Serono, Inc.$15K
  • TG Therapeutics, Inc.$9K
  • Novartis$1K
  • Teva Pharmaceuticals USA, Inc.$1K
  • Amgen$1K
  • AbbVie$600
  • plus $4K from 35 others

What the payments were for

  • Consulting fees$2,0856%
  • Speaking & faculty fees$18,00055%
  • Travel & lodging$2,1517%
  • Food & beverage$10,00231%
  • Education$3851%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$32,623 in reported general payments places this provider in the 95th percentile of 1,852 physician assistant providers in South Carolina.

See all physician assistant providers in South Carolina

Medicare billing

Part B allowed, 2024
$79,921
Medicare patients
36
Services billed
1,926

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
FingolimodFingolimod Hcl13$70,913
Nurtec OdtRimegepant Sulfate24$42,960
Dimethyl Fumarate12$42,098
UbrelvyUbrogepant23$34,972
QuliptaAtogepant21$27,100
Nucynta ErTapentadol Hcl18$21,741
Teriflunomide24$21,602
Xtampza ErOxycodone Myristate13$15,609
BotoxOnabotulinumtoxina11$12,646
Baclofen113$1,742
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine43$1,306
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen73$1,100
Modafinil29$915
Naratriptan Hcl12$889
Gabapentin71$798

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieUbrelvy, Qulipta, Botox$600$74,71855 claims
PfizerNurtec Odt$279$42,96024 claims
Upsher-smith Laboratories LLCTopiramate$23$16025 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,852 physician assistant providers in South Carolina.

Other physician assistant in Greer

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →